Verelst et al. have examined the diagnostic potential of monoclonal antibody (mAb), the conformation ability, of which appeared to depend on the specificity to Tau insert, and found that the mAb can discriminate patients with Alzheimer’s disease from healthy individuals13. The gene discussed is MAPT; the disease is Alzheimer disease.